Share
Entrepreneur
The COVID-19 vaccine may spell the end of the pandemic, but while mass vaccination is not available it is vital to stop community transmission. The new antiviral drug MK-4482 / EIDD-2801 or Molnupiravir, has managed to suppress “completely” the transmission of the coronavirus in just 24 hours , according to studies by the Institute of Biomedical Sciences of Georgia State University.
“This is the first demonstration of an orally available drug that quickly blocks the transmission of SARS-CoV-2 , so it could be a game changer,” the researchers explained in the work published in the journal Nature Microbiology .
The antiviral drug was developed at Emory University in Atlanta by the drug innovation company Drug Innovation Ventures at Emory (DRIVE), which was licensed by Ridgeback Biotherapeutics, which partnered with Merck & Co. Molnupiravir was originally designed to treat the flu and prevent the virus from making copies of itself, creating errors during viral RNA replication.
6 Dec 2020
RELATED TOPICS:
The Day Grok Lost Its Mind
15 hours ago
Police and Firefighters Respond to an Explosion Rocking the California City of Palm Springs
16 hours ago
Walz Calls Trump a ‘Tyrant’ Who Is Trampling Americans’ Rights and Violating the Rule of Law
18 hours ago
Severe Weather Leaves at Least 23 Dead, Including 14 in Storm-Battered Kentucky
19 hours ago
‘Eat the Tariffs!’: Trump Warns Walmart Not to Pass Costs to Customers
20 hours ago
Biden Audio Release Pressures Democrats Who Would Rather Talk About Trump
20 hours ago
One Person Killed in Explosion Outside Fertility Clinic; Police Say Act Was ‘Intentional’
14 hours ago
Categories

One Person Killed in Explosion Outside Fertility Clinic; Police Say Act Was ‘Intentional’

The Day Grok Lost Its Mind
